# Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

> **NCT06948760** · NA · COMPLETED · sponsor: **Mark D. DeBoer, MD, MSc., MCR** · enrollment: 11 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Control-IQ insulin pump with Lyumjev insulin
- **DEVICE:** Control-IQ insulin pump with Humalog or Novolog

## Key facts

- **NCT ID:** NCT06948760
- **Lead sponsor:** Mark D. DeBoer, MD, MSc., MCR
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-23
- **Primary completion:** 2026-02-27
- **Final completion:** 2026-03-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06948760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06948760, "Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06948760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*